* Prosomnus Inc OSA.OQ OSA.O is expected to report
resultson
March 18 for the period ending December 31 2023
* The Pleasanton California-based company is expected to
report
revenue of $7.367 million, according to the mean estimate from 3
analysts, based on LSEG data.
* LSEG's mean analyst estimate for Prosomnus Inc is for a
loss
of 31 cents per share.
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Prosomnus
Inc is
$2.00, above its last closing price of $0.64.
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM LSEG IBES ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT ESTIMATE MET, SE %
E® MISSED
Sep. 30 2023 -0.34 -0.34 -0.70 Missed -105.9
Jun. 30 2023 -0.32 -0.32 -0.01 Beat 96.9
Mar. 31 2023 -0.39 -0.39 -0.40 Missed -1.3
This summary was machine generated March 15 at 12:50 GMT. All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)